Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002002698-24-000084
Filing Date
2024-04-04
Accepted
2024-04-04 15:56:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3377
  Complete submission text file 0002002698-24-000084.txt   4757
Mailing Address 125 ELM STREET NEW CANAAN CT 06840
Business Address
Steinhart Richard I (Reporting) CIK: 0001293789 (see all company filings)

Type: 144

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38410 | Film No.: 24823054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)